Pharmaceutical News

RSS

Use of Terahertz imaging in the pharmaceutical industry talk at this year’s Photonics West by TeraView

TeraView, the pioneer and leader in terahertz technology and solutions is pleased to announce that Dr Phil Taday, Head of Applications at TeraView, will be giving an invited talk on the use of Terahertz imaging in the pharmaceutical industry at this year’s Photonics West event to be held at The Moscone Center, San Francisco, USA.

From TeraView Ltd. 30 Jan 2017

Delays in availability of new treatments and incomprehensible price rises disadvantage cancer patients

Cancer patients are living longer and in many cases the disease is becoming chronic rather than acute. Access to drugs that help extend life and improve quality of life, and fair prices for those drugs are therefore essential for more and more people.

28 Jan 2017

Researchers compile list of toxins and medicinal compounds produced by amphibian family

As human diseases become alarmingly antibiotic resistant, identification of new pharmaceuticals is critical.

28 Jan 2017

Single-molecule compounds may become basis for new antioxidant therapies

Treated particles of graphene derived from carbon nanotubes have demonstrated remarkable potential as life-saving antioxidants, but as small as they are, something even smaller had to be created to figure out why they work so well.

28 Jan 2017

Homeopathic teething tablets containing belladonna pose unnecessary risk to children, FDA warns

The U.S. Food and Drug Administration announced today that its laboratory analysis found inconsistent amounts of belladonna, a toxic substance, in certain homeopathic teething tablets, sometimes far exceeding the amount claimed on the label.

28 Jan 2017

Pulmospheres could serve as personalized, predictive model for assessing effect of IPF drugs

Pulmospheres, three dimensional multicellular spheroids composed of lung cells from individual patients, were shown to be effective in predicting the efficacy of medications for idiopathic pulmonary fibrosis, according to findings from University of Alabama at Birmingham scientists presented today in JCI Insight, a journal of the American Society for Clinical Investigation.

27 Jan 2017

PillTime: New free prescription service makes life easy for patients and carers

In the UK alone, there are 14.6 million patients who are on repeat medication. Of those, some 11.6 million are over 65 years old and will be prescribed more than five ‘regular’ items on their prescription.

27 Jan 2017

Repurposing existing drugs to treat rare diseases could improve outcomes, save money

Findacure, a rare diseases charity based in Cambridge, saysrepurposing existing drugs to treat rare diseases will improve patient outcomes and save the NHS money.

27 Jan 2017

UCLA-led researchers identify potential TB drug regimen that may cut treatment time up to 75%

Taking a new approach toward tuberculosis therapy, a UCLA-led research team has devised a potential drug regimen that could cut the treatment time by up to 75 percent, while simultaneously reducing the risk that patients could develop drug-resistant TB.

25 Jan 2017

Scientists define working mechanism of promising anti-cancer molecules

An international team of scientists, including MIPT researchers, has defined the way their promising anti-cancer molecules work.

25 Jan 2017

New treatment for C.diff infections reduces recurrences by 40%, study finds

A new treatment for Clostridium difficile (C.diff) infections reduces recurrent infections by nearly 40%, a large study has found.

25 Jan 2017

Delaying marijuana use until age 17 can be better for adolescent’s brains, says new study

The more teenagers delay smoking marijuana until they're older, the better it is for their brains, but there may be little ill effect if they start after age 17, says a new Université de Montréal study.

25 Jan 2017

Alternative influenza vaccine may provide clinical benefits and cost savings, study suggests

A study just published in Human Vaccines & Immunotherapeutics suggests that an alternative vaccine might bring clinical benefits and cost savings if used on a large scale when compared to the one currently in widest use.

25 Jan 2017

New project aims to improve efficiency of cytostatic drugs used in cancer treatment

Wilfried Weber, Professor of Synthetic Biology at the University of Freiburg, has received a grant of roughly €150,000 for his project "Hide and Seek with Cancer Drugs" in which he is working to improve the drugs used in cancer treatment

25 Jan 2017

Scientists discover cause of tumour resistance to angiogenesis inhibitors

A new study conducted by MedUni Vienna in collaboration with scientists from Hungary and Sweden has now shown for the first time that the success of specialised drugs to inhibit blood supply to tumours - so-called angiogenesis inhibitors - is compromised by the fact that these drugs do not effectively penetrate the tumour tissue and so do not reach the smallest blood vessels in the tumour.

25 Jan 2017

Functional MRI brain scan may help predict patient’s response to antidepressant therapy

A functional MRI brain scan may help predict which patients will respond positively to antidepressant therapy, according to a new study published in the journal Brain.

25 Jan 2017

TSRI scientists receive $1.8 million grant to develop drug candidates for multiple diseases

Scientists from the Florida campus of The Scripps Research Institute have been awarded approximately $1.8 million from the National Institute of General Medical Sciences of the National Institutes of Health to develop a series of drug candidates for a number of diseases, including heart disease, rheumatoid arthritis and several neurodegenerative disorders.

24 Jan 2017

Dementia patients may often struggle to manage drug regime, study reveals

New research funded by Pharmacy Research UK published on 19 January, reveals people with dementia may struggle with managing their medication - exposing them to side-effects, medication errors and an increased risk of non-adherence to drug treatment.

24 Jan 2017

New drugs that target neighbour proteins may help halt cancer progression

Cancer is caused by an accumulation of genetic changes in a cell, that overcome the normal checks and balances leading to uncontrolled growth. A complex, interacting network of proteins controls all of a cell's processes, from metabolism to growth and division.

24 Jan 2017

SCS therapy can be key to reducing use of opioids in patients battling chronic pain, study finds

New research has found spinal cord stimulation (SCS) therapy can be key to reducing or stabilizing the use of opioids in patients battling chronic pain.

20 Jan 2017

Pharmaceutical News

Use of Terahertz imaging in the pharmaceutical industry talk at this year’s Photonics West by TeraView

Delays in availability of new treatments and incomprehensible price rises disadvantage cancer patients

Researchers compile list of toxins and medicinal compounds produced by amphibian family

Single-molecule compounds may become basis for new antioxidant therapies

Homeopathic teething tablets containing belladonna pose unnecessary risk to children, FDA warns

Pulmospheres could serve as personalized, predictive model for assessing effect of IPF drugs

PillTime: New free prescription service makes life easy for patients and carers

Repurposing existing drugs to treat rare diseases could improve outcomes, save money

UCLA-led researchers identify potential TB drug regimen that may cut treatment time up to 75%

Scientists define working mechanism of promising anti-cancer molecules

New treatment for C.diff infections reduces recurrences by 40%, study finds

Delaying marijuana use until age 17 can be better for adolescent’s brains, says new study

Alternative influenza vaccine may provide clinical benefits and cost savings, study suggests

New project aims to improve efficiency of cytostatic drugs used in cancer treatment

Scientists discover cause of tumour resistance to angiogenesis inhibitors

Functional MRI brain scan may help predict patient’s response to antidepressant therapy

TSRI scientists receive $1.8 million grant to develop drug candidates for multiple diseases

Dementia patients may often struggle to manage drug regime, study reveals

New drugs that target neighbour proteins may help halt cancer progression

SCS therapy can be key to reducing use of opioids in patients battling chronic pain, study finds

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News